Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Dusunen Adam. 2018; 31(4): -


Venlafaxine-Induced Hematuria and Prostatism: A Case Report

İbrahim Gündoğmuş, Abdulkadir Karagöz, Ayhan Algül.




Abstract

Hematuria and prostatism are important medical conditions affecting quality of life. It is most often seen as the cause of prostate hyperplasia, but may be seen as a side effect of some medications. According to the literature, antidepressants rarely have urogenital side effects, but there is no report that it causes hematuria. Venlafaxine is an antidepressant that inhibited serotonin-noradrenaline reuptake used in a number of psychiatric disorders, especially in major depressive disorder in clinical practice. Although it is a safe and effective antidepressant, it can cause side effects. We present a 55-year-old man starting with hematuria and symptoms of prostatism after the use of venlafaxine and stopped after venlafaxine withdrawal. In the literature, symptoms of prostatism due to effective antidepressants have been reported through the noradrenaline mechanism such as venlafaxine, duloxetine, milnacipran and reboxetine, but there is no report on hematuria. As far as we know, this is the first report to present the case of venlafaxine-induced hematuria.

Key words: Antidepressant, hematuria, prostatism, venlafaxine






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.